Retatrutide, from Soma Pharmaceuticals , is attracting considerable attention as a novel method for weight regulation. This innovative drug merges the properties of a GLP-1 receptor stimulant and a GIP receptor stimulant, designed to not only promote weight loss but also address related metabolic